New drug XFB19 enters first human safety trial
Knowledge-focused
Recruiting now
This study is the first time the drug XFB19 is being tested in humans. It aims to check if XFB19 is safe and how the body processes it. Forty healthy adults aged 18 to 55 will receive either XFB19 or a placebo. The trial is run by Xfibra, Inc. and is currently recruiting.
Phase: PHASE1 • Sponsor: Xfibra, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC